Sake Bosch
Managing Partner @ Prime Ventures
Amsterdam, The Netherlands
Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries Sake Bosch invests in
Stages Sake Bosch invests in
Countries Sake Bosch invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.3M–$7.2M
- Series A
- $6.9M–$29M
- Series B
- $7.1M–$77M
Investment Focus
Industry
- Software 5 (15%)
- E-Commerce 5 (15%)
- Biotechnology 4 (12%)
- Food and Beverage 4 (12%)
- Apps 3 (9%)
Stage
- Seed 10 (30%)
- Series A 9 (27%)
- Series B 6 (18%)
- Pre-Seed 3 (9%)
- Series C 2 (6%)
Country
- The Netherlands 8 (24%)
- France 5 (15%)
- Israel 4 (12%)
- United Kingdom 4 (12%)
- United States 3 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Alfa AI is a recruitment technology company specializing in AI-driven hiring solutions. | $1.3M / Seed / Jul 01, 2026 | ||
| TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects. | $5.8M / Pre-Seed / Mar 30, 2026 | ||
| Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting. | $5.9M / Seed / Jan 30, 2026 | ||
| The A&B Smart Materials Using innovative cooling technologies to boost photovoltaic efficiency. | $2M / Pre-Seed / Dec 12, 2025 | ||
| Magentiq Eye Ltd. was established in 2014 with the aim to harness the most cutting edge computer vision and deep learning techniques to aid doctors in endoscopic procedures. Doctors today spend hours during Endoscopic Procedures looking at the LCD screens in order to explore, examine and treat various conditions. At Magentiq Eye we put the growingpower of Deep Learning, Image and Video Processing to the help of doctors, so they can be more accurate and effective- ultimately saving millions of lives and billions of dollars. Our first product is APDS: Automatic Polyp Detection System, developed to be used in online and offline colonoscopies. Our APDS (Automatic Polyp Detection System) can point out the suspicious locations of polyps in the videos, increasing the attentiveness of doctors during procedures, thus helping them to reduce their polyp miss-rates. Given the large population that annually undergoes colonoscopy, even a modest decrease in polyp miss-rate can save a lot of lives! The APDS- RT runs on the video feed from the endoscopic camera used by the physician in real time during the endoscopic procedure (currently only on Colonoscopy Procedure). The APDS-OFL is a software that runs in off-line mode on pre-Recorded Colonoscopy Videos. It is estimated that 40 million colonoscopy procedures are performed every year (almost 40% in the US alone). The ability of colonoscopy procedures to decrease the number of colon cancer cases has been proven without a doubt and their number expected to grow. However, researches have shown that there is about 25% of misses (undetected polyps) in those procedures, misses which can, unfortunately, cause interval cancer. Within this context The APDS can be sold as an add-on to the colonoscopy system or as a service (license per exam), paid by the clinic or hospital. Once the APDS system would be formally proven, during the next year, to improve polyp detection rate, it could be sold either jointly with the endoscopic equipment providers or it can be integrated in the colonoscopy devices. | Series A / Jul 30, 2025 | ||
| FononTech is an impulse printing company that produces fine-grained patterns in the micro to millimeter range for electronics. | $9.5M / Seed / May 16, 2025 | ||
| Faircraft is leveraging advanced synthetic biology and material science techniques to develop a lab-grown alternative to animal leather. | $15.7M / Series A / Nov 21, 2024 | ||
| FononTech specializes in impulse printing.It is used to print small electronic circuits for electronic devices. | $2.5M / Seed / Jul 11, 2023 | ||
| Mermade Seafoods is a pioneering cellular aquaculture company, bringing a novel approach and mindset for the production of cell based seafood. Our approach enables mass production of cultured seafood using a sustainable and recyclable fermentation-based process that results in clean, healthy, and sustainable protein-rich seafood products, bringingfood security for future generations.Technology:Mermade Seafoods aims to be the first company to provide a circular method of production that will revolutionize the cell-based fermentation industry by using side-stream valorisation of growth media. The company's ground breaking technology is based on upcycling biological waste products from spent growth media and turn it into new, nutrient-rich food for the growing cells. This transformative technology enables the resolution of the biggest challenges the cell-based industry is facing - high production costs, and waste accumulation. Mermade Seafoods's™ technology is based on a well-known practice in conventional aquaculture known as aquaponics, adapted to the cellular level to spearhead the next revolution of cellular agriculture by creating a new agrotech field of Cytoponics. | $3.3M / Seed / Aug 29, 2022 | ||
| Fairbrics is developing the first synthetic fiber with a net positive impact on climate change and capable of meeting the demand of the market. | $7.2M / Seed / Mar 09, 2022 | ||
| See all 33 investments → | |||
Co-Investors
About Prime Ventures
Prime Ventures is a venture capital firm focusing on investing in European companies in the technology and related industries and leverages its capital, experience and network to actively guide them into global category leaders. The firm has invested in companies in the Benelux countries, United Kingdom, France, Finland and Sweden. From itsoffices in The Netherlands and the UK the independent partnership manages over EUR700 million in committed capital.(Source :
Prime Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Joost Holleman
Partner
|
|||
Ilja Bobbert
Founder & Managing Partner
|
|||
Margaret Perchik
Partner
|
|||
Martijn van Heeswijk
Associate
|
|||
Monish Suri
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sake Bosch invest in?
Sake Bosch invests primarily in Software, E-Commerce and Biotechnology startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Sake Bosch invest in?
Sake Bosch typically joins rounds of $1.3M–$7.2M at Seed, $6.9M–$29M at Series A and $7.1M–$77M at Series B. These are whole funding-round sizes, not Sake Bosch's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sake Bosch took part in.
How do I contact Sake Bosch?
Public channels for Sake Bosch include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sake Bosch last invest?
The most recent investment recorded for Sake Bosch closed in Jul 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
